GSA Capital Partners’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,398
Closed -$197K 2027
2025
Q3
$197K Buy
16,398
+14,167
+635% +$173K 0.02% 1437
2025
Q2
$19K Buy
+2,231
New +$22.7K ﹤0.01% 1691
2025
Q1
Sell
-2,835
Closed -$58K 2011
2024
Q4
$58K Sell
2,835
-6,024
-68% -$176K ﹤0.01% 1529
2024
Q3
$352K Sell
8,859
-9,277
-51% -$250K 0.03% 1140
2024
Q2
$319K Buy
+18,136
New +$307K 0.02% 1244
2018
Q1
Sell
-115
Closed -$74K 1789
2017
Q4
$74K Sell
115
-257
-69% -$181K ﹤0.01% 1488
2017
Q3
$351K Sell
372
-324
-47% -$248K 0.02% 1168
2017
Q2
$607K Buy
696
+476
+216% +$390K 0.04% 891
2017
Q1
$151K Buy
+220
New +$145K 0.01% 1620
2015
Q2
Sell
-98
Closed -$118K 2154
2015
Q1
$118K Buy
98
+4
+4% +$4.68K ﹤0.01% 2000
2014
Q4
$106K Buy
+94
New +$96.4K 0.01% 1582
2014
Q1
Sell
-185
Closed -$212K 1766
2013
Q4
$212K Buy
+185
New +$255K 0.02% 1435

Other funds holding RMTI

GSA Capital Partners's RMTI Position: Q4 2025 in Review

GSA Capital Partners sold out of Rockwell Medical (RMTI) in Q4 2025, closing a stake of 16,398 shares — an estimated $197K sold.

GSA Capital Partners first reported a position in RMTI in Q4 2013 and held it in 12 quarters. The position peaked at $607K in Q2 2017. 36 funds tracked by Wall St. Rank hold RMTI as of Q4 2025.

  • GSA Capital Partners reported no remaining Rockwell Medical position as of Q4 2025 after selling out during the quarter.
  • GSA Capital Partners sold 16,398 Rockwell Medical shares in Q4 2025, an estimated $197K.
  • GSA Capital Partners first reported a position in Rockwell Medical in Q4 2013 and held it in 12 quarters.
  • GSA Capital Partners's Rockwell Medical position peaked at $607K in Q2 2017.
  • 36 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2025.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.